Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
Author:
Funder
Shanghai Municipal Health Bureau
National Institutes of Health
MD Anderson's Cancer Center Support Grant
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference41 articles.
1. Ovarian cancer;Jayson;Lancet,2014
2. Treatment of ovarian cancer in the older woman;Tew;Gynecol. Oncol,2015
3. New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances;Liu;Clin. Cancer Res,2014
4. “Platinum resistant” ovarian cancer: what is it, who to treat and how to measure benefit?;Davis;Gynecol. Oncol,2014
5. Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer;Della;Onco. Targets. Ther,2014
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Copper peroxide and cisplatin co-loaded silica nanoparticles-based trinity strategy for cooperative cuproptosis/chemo/chemodynamic cancer therapy;Chemical Engineering Journal;2024-02
2. Emergence of metal-based anticancer therapeutics: A promising perspective;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024
3. Ezetimibe ameliorates cisplatin‐induced nephrotoxicity: A novel therapeutic approach via modulating AMPK/Nrf2/TXNIP signaling;The FASEB Journal;2023-12-25
4. Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel;Annals of Medicine;2023-12-12
5. Research progress on the mechanism of glycolysis in ovarian cancer;Frontiers in Immunology;2023-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3